REGENXBIO Inc. (RGNX) has 165 open-market insider trades by 13 insiders since 2015. Over the last six months insiders net bought $949K. The most active filer is Kenneth T. Mills, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Kenneth T. Mills | Dir | — | 44 | $22.1M | 2026-05-29 |
| Curran Simpson | CEO | — | 16 | $19.7M | 2026-07-01 |
| Vittal Vasista | CFO | — | 37 | $18.6M | 2024-03-19 |
| Allan M. Fox | Dir | — | 2 | $12.2M | 2026-05-29 |
| Donald J. Hayden Jr. | Dir | — | 15 | $9.3M | 2020-02-10 |
| Stephen Yoo | — | — | 10 | $8.6M | 2018-12-03 |
| Patrick J. Christmas | — | — | 16 | $6.3M | 2026-08-01 |
| Luke M. Beshar | Dir | — | 3 | $4.1M | 2018-11-29 |
| Deerfield Mgmt III, L.P. via James E. Flynn | 10% | — | 1 | $3.9M | 2015-09-22 |
| FMR LLC | — | — | 15 | $3.1M | 2016-05-17 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Gregory Austin Ciongoli | Director | Buy | $949K | 2026-08-26 |
| Steve Pakola | — | Sell | $29K | 2026-07-02 |
| Steve Pakola | — | Sell | $689K | 2026-06-29 |
| Steve Pakola | — | Sell | $169K | 2026-05-11 |
| Steve Pakola | Chief Medical Officer | Sell | $53K | 2026-03-10 |
| Curran Simpson | CEO | Sell | $525K | 2025-10-09 |
Companies that share insiders with RGNX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Curran Simpson | CEO | Sell | $153K | 2025-09-29 |
| Curran Simpson | CEO | Sell | $155K | 2025-09-10 |
| Kenneth T. Mills | Director | Sell | $326K | 2025-05-12 |
| Argeris N. Karabelas | Director | Sell | $101K | 2024-10-01 |
| Argeris N. Karabelas | Director | Sell | $116K | 2024-09-03 |
| Curran Simpson | CEO | Sell | $2K | 2024-08-01 |
| Argeris N. Karabelas | Director | Sell | $136K | 2024-08-01 |
| Argeris N. Karabelas | Director | Sell | $166K | 2024-07-29 |
| Curran Simpson | CEO | Sell | $290K | 2024-07-29 |